Invesco Ltd. - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 139 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$69,000
+13.1%
51,274
-4.7%
0.00%
Q4 2018$61,000
-51.6%
53,787
+17.7%
0.00%
Q3 2018$126,000
-22.2%
45,687
+0.9%
0.00%
Q2 2018$162,000
-50.0%
45,282
-11.9%
0.00%
Q4 2017$324,000
-8.2%
51,382
-0.5%
0.00%
Q3 2017$353,000
+3.8%
51,639
+8.4%
0.00%
Q2 2017$340,000
-57.8%
47,633
-45.7%
0.00%
Q1 2017$806,000
+475.7%
87,682
+152.8%
0.00%
Q4 2016$140,000
+17.6%
34,690
+11.7%
0.00%
Q3 2016$119,000
-10.5%
31,067
+0.7%
0.00%
Q2 2016$133,000
-93.8%
30,843
-31.3%
0.00%
-100.0%
Q2 2015$2,129,000
+29.4%
44,883
-0.0%
0.00%0.0%
Q1 2015$1,645,000
+18.9%
44,895
+28.9%
0.00%0.0%
Q4 2014$1,383,000
-11.5%
34,817
-55.5%
0.00%0.0%
Q3 2014$1,562,000
+2197.1%
78,303
+1466.1%
0.00%
Q4 2013$68,000
+47.8%
5,000
+25.0%
0.00%
Q3 2013$46,0004,0000.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2015
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 300,000$1,209,0000.23%
Rock Springs Capital Management LP 698,000$2,813,0000.19%
Eventide Asset Management 600,000$2,418,0000.16%
Teza Capital Management LLC 14,369$58,0000.08%
Candriam S.C.A. 374,000$1,507,0000.04%
R&F Capital Advisors LP 23,778$96,0000.03%
Tekla Capital Management LLC 192,322$775,0000.03%
Sunbelt Securities, Inc. 6,000$24,180,0000.03%
DOW CHEMICAL CO /DE/ 65,000$249,0000.03%
CANADA PENSION PLAN INVESTMENT BOARD 1,654,100$6,666,0000.02%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders